144 related articles for article (PubMed ID: 14506180)
1. Therapeutic potential of chimeric amyloid-reactive monoclonal antibody 11-1F4.
Solomon A; Weiss DT; Wall JS
Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3831S-8S. PubMed ID: 14506180
[TBL] [Abstract][Full Text] [Related]
2. Radioimaging of light chain amyloid with a fibril-reactive monoclonal antibody.
Wall JS; Kennel SJ; Paulus M; Gregor J; Richey T; Avenell J; Yap J; Townsend D; Weiss DT; Solomon A
J Nucl Med; 2006 Dec; 47(12):2016-24. PubMed ID: 17138745
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy in systemic primary (AL) amyloidosis using amyloid-reactive monoclonal antibodies.
Solomon A; Weiss DT; Wall JS
Cancer Biother Radiopharm; 2003 Dec; 18(6):853-60. PubMed ID: 14969598
[TBL] [Abstract][Full Text] [Related]
4. Bifunctional amyloid-reactive peptide promotes binding of antibody 11-1F4 to diverse amyloid types and enhances therapeutic efficacy.
Wall JS; Williams AD; Foster JS; Richey T; Stuckey A; Macy S; Wooliver C; Campagna SR; Tague ED; Farmer AT; Lands RH; Martin EB; Heidel RE; Kennel SJ
Proc Natl Acad Sci U S A; 2018 Nov; 115(46):E10839-E10848. PubMed ID: 30377267
[TBL] [Abstract][Full Text] [Related]
5. Antibody-mediated resolution of light chain-associated amyloid deposits.
Hrncic R; Wall J; Wolfenbarger DA; Murphy CL; Schell M; Weiss DT; Solomon A
Am J Pathol; 2000 Oct; 157(4):1239-46. PubMed ID: 11021828
[TBL] [Abstract][Full Text] [Related]
6. Localization of a conformational epitope common to non-native and fibrillar immunoglobulin light chains.
O'Nuallain B; Allen A; Kennel SJ; Weiss DT; Solomon A; Wall JS
Biochemistry; 2007 Feb; 46(5):1240-7. PubMed ID: 17260953
[TBL] [Abstract][Full Text] [Related]
7. Phage display and peptide mapping of an immunoglobulin light chain fibril-related conformational epitope.
O'Nuallain B; Allen A; Ataman D; Weiss DT; Solomon A; Wall JS
Biochemistry; 2007 Nov; 46(45):13049-58. PubMed ID: 17944486
[TBL] [Abstract][Full Text] [Related]
8. Phase 1a/b study of monoclonal antibody CAEL-101 (11-1F4) in patients with AL amyloidosis.
Edwards CV; Rao N; Bhutani D; Mapara M; Radhakrishnan J; Shames S; Maurer MS; Leng S; Solomon A; Lentzsch S; Eisenberger A
Blood; 2021 Dec; 138(25):2632-2641. PubMed ID: 34521113
[TBL] [Abstract][Full Text] [Related]
9. AL amyloid imaging and therapy with a monoclonal antibody to a cryptic epitope on amyloid fibrils.
Wall JS; Kennel SJ; Williams A; Richey T; Stuckey A; Huang Y; Macy S; Donnell R; Barbour R; Seubert P; Schenk D
PLoS One; 2012; 7(12):e52686. PubMed ID: 23300743
[TBL] [Abstract][Full Text] [Related]
10. Construction and expression of chimeric antibodies by a simple replacement of heavy and light chain V genes into a single cassette vector.
Kanda H; Mori K; Koga H; Taniguchi K; Kobayashi H; Sakahara H; Konishi J; Endo K; Watanabe T
Hybridoma; 1994 Oct; 13(5):359-66. PubMed ID: 7860092
[TBL] [Abstract][Full Text] [Related]
11. Chimeric (mouse/human) anti-colon cancer antibody c30.6 inhibits the growth of human colorectal cancer xenografts in scid/scid mice.
Mount PF; Sutton VR; Li W; Burgess J; McKEnzie IF; Pietersz GA; Trapani JA
Cancer Res; 1994 Dec; 54(23):6160-6. PubMed ID: 7954462
[TBL] [Abstract][Full Text] [Related]
12. Structural analysis of gamma delta TCR using a novel set of TCR gamma and delta chain-specific monoclonal antibodies generated against soluble gamma delta TCR. Evidence for a specific conformation adopted by the J delta 2 region and for a V delta 1 polymorphism.
Romagné F; Peyrat MA; Leget C; Davodeau F; Houde I; Necker A; Hallet MM; Vié H; Bonneville M
J Immunol Methods; 1996 Jan; 189(1):25-36. PubMed ID: 8576577
[TBL] [Abstract][Full Text] [Related]
13. Radioimmunodetection of amyloid deposits in patients with AL amyloidosis.
Wall JS; Kennel SJ; Stuckey AC; Long MJ; Townsend DW; Smith GT; Wells KJ; Fu Y; Stabin MG; Weiss DT; Solomon A
Blood; 2010 Sep; 116(13):2241-4. PubMed ID: 20522711
[TBL] [Abstract][Full Text] [Related]
14. Construction and expression of a mouse-human chimeric antibody against human tumor necrosis factor-alpha.
Nagahira K; Fukuda Y; Nasu T; Kawashima H; Noguchi C; Kurihara T; Oikawa S; Nakanishi T
Immunol Lett; 1998 Dec; 64(2-3):139-44. PubMed ID: 9870665
[TBL] [Abstract][Full Text] [Related]
15. Molecular modeling and preclinical evaluation of the humanized NR-LU-13 antibody.
Graves SS; Goshorn SC; Stone DM; Axworthy DB; Reno JM; Bottino B; Searle S; Henry A; Pedersen J; Rees AR; Libby RT
Clin Cancer Res; 1999 Apr; 5(4):899-908. PubMed ID: 10213227
[TBL] [Abstract][Full Text] [Related]
16. Genetic engineering, expression, and activity of a chimeric monoclonal antibody-avidin fusion protein for receptor-mediated delivery of biotinylated drugs in humans.
Boado RJ; Zhang Y; Zhang Y; Xia CF; Wang Y; Pardridge WM
Bioconjug Chem; 2008 Mar; 19(3):731-9. PubMed ID: 18278853
[TBL] [Abstract][Full Text] [Related]
17. Primary structures of three Armenian hamster monoclonal antibodies specific for idiotopes and metatopes of the monoclonal anti-fluorescein antibody 4-4-20.
Mallender WD; Voss EW
Mol Immunol; 1995 Oct; 32(14-15):1093-103. PubMed ID: 8544859
[TBL] [Abstract][Full Text] [Related]
18. Binding activities and antitumor properties of a new mouse/human chimeric antibody specific for GD2 ganglioside antigen.
Alvarez-Rueda N; Leprieur S; Clémenceau B; Supiot S; Sébille-Rivain V; Faivre-Chauvet A; Davodeau F; Paris F; Barbet J; Aubry J; Birklé S
Clin Cancer Res; 2007 Sep; 13(18 Pt 2):5613s-5620s. PubMed ID: 17875797
[TBL] [Abstract][Full Text] [Related]
19. Interim analysis of the phase 1a/b study of chimeric fibril-reactive monoclonal antibody 11-1F4 in patients with AL amyloidosis.
Edwards CV; Gould J; Langer AL; Mapara M; Radhakrishnan J; Maurer MS; Raza S; Mears JG; Wall J; Solomon A; Lentzsch S
Amyloid; 2017 Mar; 24(sup1):58-59. PubMed ID: 28434347
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
